bcbstx glp-1 coverage bcbstx glp-1 coverage Perspectives from

Weiss and everyone at Wellness & Longevity Medical

GLP-1 therapies are reshaping obesity, diabetes, and even cardiovascular care Demand has outpaced global manufacturing capacity A grey market has emerged and regulators are now stepping in to contain it Patients want affordable, available treatment

People who are having trouble with memory and understanding, lethargy and fatigue, depression and irritability, and dizziness or faintness might be experiencing a deficiency of vitamin B-12

The development of drugs that do not cause weight gain or severe hypoglycemia and lower postprandial glucose levels have resulted in the limited use of meglitinides